Treating type 2 diabetes with canagliflozin

S D Med. 2013 Jul;66(7):280-1.
No abstract available

MeSH terms

  • Blood Pressure / drug effects
  • Body Weight / drug effects
  • Canagliflozin
  • Cholesterol, HDL / drug effects
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Glucosides / pharmacology
  • Glucosides / therapeutic use*
  • Humans
  • Sodium-Glucose Transporter 2 Inhibitors*
  • Thiophenes / pharmacology
  • Thiophenes / therapeutic use*
  • Treatment Outcome

Substances

  • Cholesterol, HDL
  • Glucosides
  • Sodium-Glucose Transporter 2 Inhibitors
  • Thiophenes
  • Canagliflozin